Assay of lapatinib in murine models of cigarette smoke carcinogenesis

Lapatinib, a dual tyrosine kinase inhibitor targeting the epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor 2 (HER-2), is prescribed for the treatment of patients with metastatic breast cancer overexpressing HER-2. Involvement of this drug in pulmonary carcinogenesis...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Balansky, Roumen, Izzotti, Alberto, D’Agostini, Francesco, Longobardi, Mariagrazia, Micale, Rosanna T., La Maestra, Sebastiano, Camoirano, Anna, Ganchev, Gancho, Iltcheva, Marietta, Steele, Vernon E., De Flora, Silvio
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2014
Matèries:
Original Manuscript
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4178471/
https://ncbi.nlm.nih.gov/pubmed/25053627
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/carcin/bgu154
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars